Ethinyl Estradiol and Norethindrone Acet... Clinical Trials

• Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00006133 - Completed
  Systemic Lupus Erythematosus
  
• The Effects of Continuous Administration of a Monophasic Oral Contraceptive (Norethindrone Acetate/Ethinyl Estradiol 1/20ug) on Bleeding Days and Endometrial and Ovarian Function
  ClinicalTrials.gov Identifier: NCT00128726 - Active, not recruiting
  menstrual cycle
  
• Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003771 - Active, not recruiting
  menopausal symptoms; stage I breast cancer; stage II breast cancer; breast cancer in situ
  
• Hormone Replacement Therapy and Insulin Action: A Double-Blind, Parallel, Placebo-Controlled Hormone Intervention Study in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00005769 - Active, not recruiting
  Menopause
  
• Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)
  ClinicalTrials.gov Identifier: NCT00458458 - Recruiting
  Endometriosis; Dysmenorrhea; Dyspareunia
  
• Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00044837 - Terminated
  HIV Infections
  
• An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen
  ClinicalTrials.gov Identifier: NCT00320580 - Completed
  Metrorrhagia
  
• Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
  ClinicalTrials.gov Identifier: NCT00080756 - Recruiting
  Breast Cancer
  
• Phase II Randomized Study of Leuprolide vs Oral Contraceptive Therapy vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism
  ClinicalTrials.gov Identifier: NCT00004763 - Completed
  Hyperandrogenism
  
• Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS
  ClinicalTrials.gov Identifier: NCT00161681 - Completed
  Premenstrual Syndrome
  
• Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
  ClinicalTrials.gov Identifier: NCT00000559 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia; Postmenopause
  
• Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysporic Disorder
  ClinicalTrials.gov Identifier: NCT00128934 - Completed
  Premenstrual Dysphoric Disorder
  
• Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
  ClinicalTrials.gov Identifier: NCT00195559 - Completed
  Premenstrual Syndrome; Menstruation Disturbances
  
• POPART''MUS : Prevention of Post Partum Relapses with Progestin and Estradiol in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00127075 - Recruiting
  Multiple Sclerosis
  
• Hormone Replacement Therapy (HRT) Website Tool
  ClinicalTrials.gov Identifier: NCT00319072 - Completed
  Communication; Menopause; Hormone Replacement Therapy
  
• Hormone Therapy in Preventing Endometrial Carcinogenesis (Cancer) in Women With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
  ClinicalTrials.gov Identifier: NCT00033358 - Recruiting
  Endometrial Cancer; hereditary non-polyposis colon cancer (hMSH2, hMLH1, hPMS1, hPMS2)
  
• Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks.
  ClinicalTrials.gov Identifier: NCT00331071 - Active, not recruiting
  Female Contraception; Contraception
  
• Hormonal Birth Control and the Risk of Acquiring HIV
  ClinicalTrials.gov Identifier: NCT00006324 - Completed
  HIV Infections; HIV Seronegativity
  
• Reduction of Triglycerides in Women on HRT
  ClinicalTrials.gov Identifier: NCT00023543 - Active, not recruiting
  Cardiovascular Diseases; Atherosclerosis; Postmenopause; Heart Diseases
  
• Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women
  ClinicalTrials.gov Identifier: NCT00447863 - Not yet recruiting
  Contraception
  
• Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death
  ClinicalTrials.gov Identifier: NCT00580775 - Enrolling by invitation
  Menopausal Women
  
• Study of External Beam Radiation Therapy with and Without Hormonal Therapy to Treat Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00116220 - Active, not recruiting
  Prostate Cancer
  
• Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol
  ClinicalTrials.gov Identifier: NCT00263341 - Recruiting
  Contraception
  
• Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients with Turner Syndrome
  ClinicalTrials.gov Identifier: NCT00001221 - Completed
  Gonadal Dysgenesis; Turner's Syndrome
  
• Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).
  ClinicalTrials.gov Identifier: NCT00185458 - Active, not recruiting
  Menopause
  
• A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00152295 - Completed
  Postmenopausal, hormone replacement therapy
  
• A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00152282 - Completed
  Postmenopausal, hormone replacement therapy
  
• Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Using Oral Contraceptive
  ClinicalTrials.gov Identifier: NCT00377988 - Active, not recruiting
  Female Contraception; Contraception
  
• Hormone Therapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003026 - Active, not recruiting
  adenocarcinoma of the prostate
  
• Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array
  ClinicalTrials.gov Identifier: NCT00318318 - Active, not recruiting
  Healthy; Estrogen Replacement Therapy
  
• Transdermal Estradiol in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy and Chemotherapy
  ClinicalTrials.gov Identifier: NCT00255632 - Recruiting
  Prostate Cancer
  
• Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome
  ClinicalTrials.gov Identifier: NCT00134745 - Recruiting
  Turner Syndrome
  
• Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)
  ClinicalTrials.gov Identifier: NCT00497484 - Active, not recruiting
  Pseudohypoparathyroidism; Growth Hormone Deficiency, Dwarfism
  
• Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00110045 - Recruiting
  Cancer; Infection
  
• Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-Menopausal Women
  ClinicalTrials.gov Identifier: NCT00560924 - Terminated
  Hormone Replacement Therapy, Post-Menopausal
  
• Development and Evaluation of a Hormone Replacement Therapy Decision-Aid
  ClinicalTrials.gov Identifier: NCT00012909 - Completed
  Menopause
  
• Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density
  ClinicalTrials.gov Identifier: NCT00117260 - Not yet recruiting
  Osteopenia
  
• Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa
  ClinicalTrials.gov Identifier: NCT00320567 - Completed
  Osteoporosis
  
• Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer
  
• SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
  
• Phase I Study of Abiraterone Acetate in Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00473746 - Recruiting
  Hormone Refractory Prostate Cancer
  
• Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
  recurrent prostate cancer; Anemia; Fatigue
  
• An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
  ClinicalTrials.gov Identifier: NCT00344383 - Completed
  Metrorrhagia
  
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• Radiologic Evaluation and Breast Density (READ)
  ClinicalTrials.gov Identifier: NCT00117663 - Recruiting
  Breast Cancer
  
• Combination Therapy in Treating Patients With Advanced Prostate Cancer That Have Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00004001 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception
  ClinicalTrials.gov Identifier: NCT00248963 - Completed
  Oral Contraceptive
  
• Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
  ClinicalTrials.gov Identifier: NCT00245921 - Completed
  Contraception
  
• Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation
  ClinicalTrials.gov Identifier: NCT00254189 - Completed
  Ovulation
  
• Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003915 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer
  
• Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00324259 - Recruiting
  Breast Neoplasms
  
• Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00028769 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00104715 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Hormone Therapy in Treating Patients Who Have Stage I or Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003645 - Active, not recruiting
  stage II prostate cancer; stage I prostate cancer
  
• Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00027859 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer
  
• Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00103376 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• An Open-Label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol
  ClinicalTrials.gov Identifier: NCT00307632 - Completed
  Contraception
  
• Postmenopausal Hormone Therapy in Unstable Angina
  ClinicalTrials.gov Identifier: NCT00000601 - Completed
  Angina, Unstable; Cardiovascular Diseases; Coronary Disease; Heart Diseases; Postmenopause
  
• Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004054 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003437 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia
  
• Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)
  ClinicalTrials.gov Identifier: NCT00523406 - Active, not recruiting
  Macular Degeneration
  
• Zoledronate and Estradiol in Preventing Bone Loss in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00049491 - Recruiting
  Osteoporosis; stage III prostate cancer; stage IV prostate cancer
  
• High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00131924 - Active, not recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00288080 - Recruiting
  Prostate Cancer
  
• Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003124 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00006044 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00176644 - Recruiting
  Prostate Cancer
  
• Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
  ClinicalTrials.gov Identifier: NCT00008359 - Active, not recruiting
  Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; Eye Cancer; kidney tumor
  
• Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002633 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004124 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
  
• Rapid Hormone Cycling With Testosterone and Leuprolide Combined With Docetaxel in Treating Patients With Recurrent or Metastatic Adenocarcinoma (Cancer) of the Prostate
  ClinicalTrials.gov Identifier: NCT00070369 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer
  ClinicalTrials.gov Identifier: NCT00079248 - Active, not recruiting
  Osteoporosis; stage I breast cancer; stage II breast cancer; menopausal symptoms; Hot Flashes
  
• Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00010231 - Active, not recruiting
  stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00081159 - Active, not recruiting
  recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003734 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
  refractory plasma cell neoplasm
  
• ELITE: Early versus Late Intervention Trial with Estradiol
  ClinicalTrials.gov Identifier: NCT00114517 - Recruiting
  Atherosclerosis
  
• Evaluation of Women's Experience With EVRA® (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.
  ClinicalTrials.gov Identifier: NCT00261482 - Completed
  Contraception; Female Contraception
  
• Tipifarnib and Fulvestrant as Second-Line Therapy in Treating Postmenopausal Women With Hormone Receptor-Positive Inoperable Locally Advanced or Metastatic Breast Cancer With Progressive Disease After Previous First-Line Endocrine Therapy
  ClinicalTrials.gov Identifier: NCT00082810 - Active, not recruiting
  recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
  
• Efficacy of Gynodian® Depot in Women With Impaired Well-Being
  ClinicalTrials.gov Identifier: NCT00463450 - Completed
  Hormone Replacement Therapy
  
• Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD.
  ClinicalTrials.gov Identifier: NCT00041483 - Active, not recruiting
  Macular Degeneration
  
• Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
  ClinicalTrials.gov Identifier: NCT00055731 - Recruiting
  stage III prostate cancer; stage II prostate cancer
  
• Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women
  ClinicalTrials.gov Identifier: NCT00319163 - Completed
  Healthy
  
• Clinical Study of Abiraterone Acetate and Prednisone in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00485303 - Recruiting
  Hormone Refractory Prostate Cancer
  
• Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00030654 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
  
• Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00099086 - Recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Tranexamic Acid Vs. Quixil - Reducing Blood Loss in Joint Replacement
  ClinicalTrials.gov Identifier: NCT00378872 - Recruiting
  Hemorrhage; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee
  
• Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002855 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
  
• Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003290 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer
  
• Hormone Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003323 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life; sexual dysfunction and infertility
  
• Combination Chemotherapy in Treating Women With Stage I Breast Cancer
  ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
  stage I breast cancer
  
• Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00066690 - Recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Hormone Replacement Therapy and Prothrombotic Variants
  ClinicalTrials.gov Identifier: NCT00049933 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Cerebrovascular Accident; Myocardial Infarction; Hypertension
  
• PS-341 in Treating Patients With Refractory or Progressive Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049478 - Active, not recruiting
  refractory plasma cell neoplasm
  
• Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00002976 - Completed
  stage I endometrial cancer; stage II endometrial cancer; endometrial adenocarcinoma
  
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients
  ClinicalTrials.gov Identifier: NCT00411853 - Recruiting
  Hormone Refractory Prostate Cancer
  
• Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT)
  ClinicalTrials.gov Identifier: NCT00326781 - Active, not recruiting
  Smoking
  
• REPLACE: Implantable Cardiac Pulse Generator Replacement Registry
  ClinicalTrials.gov Identifier: NCT00395447 - Recruiting
  Device Replacement; Elective Replacement (ERI); Device Advisory; Device Upgrade; Postoperative Complications